Arrivent Biopharma, Inc. · NASDAQ:AVBP
The Vanguard Group's stake in Arrivent Biopharma, Inc. fell to 4.52% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 30, 2026
The Vanguard Group's stake in Arrivent Biopharma, Inc. fell to 4.52%, 1,869,266 shares, as a passive investor on Dec 31, 2025. Filed Jan 30, 2026 (Schedule 13G/A).
- Stake
- 4.52%
- Shares
- 1,869,266
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 4.52% | 1,869,266 |
Source
Related
- Arrivent Biopharma, Inc.
- The Vanguard Group
- Arrivent Biopharma, Inc. shareholders
- Schedule 13G · The Vanguard Group · Oct 30, 2025
- Schedule 13G · Vivo Opportunity, LLC · Oct 13, 2026
- Schedule 13D/A · Orbimed Advisors LLC · Oct 8, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · Sofinnova Venture Partners IX, L.P. ("SVP IX") · Mar 5, 2026